文献速递神经核医学

阿尔茨海默病与额颞叶痴呆18F-FDG PET采集时间与给药活度降低的限度

Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia.
PubMed 文献 · J Nucl Med · 2019-04-26

该研究纳入临床诊断阿尔茨海默病(AD,n=13)或额颞叶痴呆(FTD,n=12)患者,注射210±9 MBq 18F-FDG后行PET/CT,通过列表模式重建模拟不同采集时间与给药活度。结果显示采集时间可缩短至2分钟(原10分钟的1/4)而不影响诊断质量,给药活度可降至50 MBq使有效剂量低于1 mSv。

要点

  • 采集时间可缩短至2分钟,区域均值摄取值变化小于5%,体素水平组间对比显著体素仅减少5%。
  • 视觉判读在缩短至30秒时诊断不变,诊断确定性在3分钟和2分钟时仅轻微下降(Cohen's d=0.3)。
  • 10分钟采集条件下给药活度可降至50 MBq,PET检查有效剂量低于1 mSv。

核心结论

  • 区域和体素水平的统计结果及单受试者视觉判读均显示,典型10分钟采集时间可缩短4倍而不影响诊断质量。
  • 在10分钟采集时间和相似效应量下,给药活度可降至50 MBq,使PET检查有效剂量低于1 mSv。

研究设计与样本

  • 纳入临床诊断AD(n=13)或FTD(n=12)患者,注射210±9 MBq 18F-FDG后行PET/CT。
  • 列表模式数据重建模拟15种采集时间(10分钟至2秒),并行基于感兴趣区和体素水平的统计分析及组间对比。
  • 3名读者对7种采集时间(低至30秒)进行盲法视觉判读,提供AD或FTD诊断及个体诊断确定性,共450次判读。

主要发现

  • 采集时间降至1分钟时,除1例患者后扣带回皮层外,所有区域和患者的区域平均摄取值变化小于5%。
  • 体素水平组间对比提示2分钟测量时间已足够,显著体素数量仅减少5%且空间模式维持。
  • 450次缩短时间视觉判读中原始诊断均未改变,诊断确定性在3分钟和2分钟时仅缓慢轻度下降,效应量小(Cohen's d=0.3)。

关键数值与推荐

  • 区域平均摄取值变化小于5%对应采集时间低至1分钟(1例后扣带回皮层除外)。
  • 体素水平组间对比显著体素减少5%对应采集时间2分钟。
  • 诊断确定性效应量Cohen's d=0.3对应采集时间3分钟和2分钟(对比原始10分钟)。
  • 给药活度可降至50 MBq对应10分钟采集时间和相似效应量,有效剂量低于1 mSv。

临床怎么用

  • AD和FTD的18F-FDG PET采集时间可从10分钟缩短至2分钟,有助于提高患者依从性。
  • 在保持10分钟采集时间时,给药活度可降至50 MBq以降低辐射剂量,同时不损害诊断质量。

局限性

  • 样本量较小(AD 13例,FTD 12例),视觉判读仅3名读者。
  • 结果为基于列表模式数据重建的模拟缩短采集时间,非实际前瞻性缩短采集验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We evaluated the effect of a reduced acquisition time for 18F-FDG PET studies of Alzheimer dementia (AD) and frontotemporal dementia (FTD) to derive a limit for reductions of acquisition time (improving patient compliance) and administered activity (lowering the radiation dose) with uncompromised diagnostic outcome. Methods: We included patients with a clinical diagnosis of AD (n = 13) or FTD (n = 12) who were examined with 18F-FDG PET/CT after injection of 210 ± 9 MBq of 18F-FDG. List-mode data were reconstructed over various time intervals simulating reduced acquisition times or administered activities. Volume-of-interest-based and voxelwise statistical analyses including group contrasts were performed for 15 different acquisition times ranging from 10 min to 2 s. In addition, masked visual reads were obtained from 3 readers independently for 7 different acquisition times down to 30 s, providing a diagnosis of either AD or FTD and the individual diagnostic certainty. Results: Regional mean uptake changed by less than 5% at a reduced acquisition time down to 1 min in all regions and patients except for the posterior cingulate cortex of 1 patient. Voxelwise group contrasts suggest a sufficient measurement time of only 2 min, for which the number of significant voxels decreased by merely 5% while maintaining their spatial pattern. In 450 visual reads at reduced times, no change in the original diagnosis was observed. The diagnostic certainty showed only a very slow and mild decline, with small effect sizes (Cohen's d) of 0.3, at acquisition times of 3 and 2 min compared with the original results at 10 min. Conclusion: Statistical results at a region and voxel level, as well as single-subject visual reads, reveal a considerable potential to reduce the typical 10-min acquisition time (by a factor of 4) without compromising diagnostic quality. Conversely, our data suggest that for a given acquisition time of 10 min and a similar effect size, the administered activity may be reduced to 50 MBq, resulting in an effective dose of less than 1 mSv for the PET examination.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Schiller F, Frings L, Thurow J, et al. Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia. J Nucl Med. 2019. PMID: 31028167. doi:10.2967/jnumed.119.227132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。